Literature DB >> 24084685

Metabolic labeling of leucine rich repeat kinases 1 and 2 with radioactive phosphate.

Jean-Marc Taymans1, Fangye Gao, Veerle Baekelandt.   

Abstract

Leucine rich repeat kinases 1 and 2 (LRRK1 and LRRK2) are paralogs which share a similar domain organization, including a serine-threonine kinase domain, a Ras of complex proteins domain (ROC), a C-terminal of ROC domain (COR), and leucine-rich and ankyrin-like repeats at the N-terminus. The precise cellular roles of LRRK1 and LRRK2 have yet to be elucidated, however LRRK1 has been implicated in tyrosine kinase receptor signaling, while LRRK2 is implicated in the pathogenesis of Parkinson's disease. In this report, we present a protocol to label the LRRK1 and LRRK2 proteins in cells with (32)P orthophosphate, thereby providing a means to measure the overall phosphorylation levels of these 2 proteins in cells. In brief, affinity tagged LRRK proteins are expressed in HEK293T cells which are exposed to medium containing (32)P-orthophosphate. The (32)P-orthophosphate is assimilated by the cells after only a few hours of incubation and all molecules in the cell containing phosphates are thereby radioactively labeled. Via the affinity tag (3xflag) the LRRK proteins are isolated from other cellular components by immunoprecipitation. Immunoprecipitates are then separated via SDS-PAGE, blotted to PVDF membranes and analysis of the incorporated phosphates is performed by autoradiography ((32)P signal) and western detection (protein signal) of the proteins on the blots. The protocol can readily be adapted to monitor phosphorylation of any other protein that can be expressed in cells and isolated by immunoprecipitation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24084685      PMCID: PMC3923590          DOI: 10.3791/50523

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  23 in total

1.  Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant.

Authors:  Veronique Daniëls; Renée Vancraenenbroeck; Bernard M H Law; Elisa Greggio; Evy Lobbestael; Fangye Gao; Marc De Maeyer; Mark R Cookson; Kirsten Harvey; Veerle Baekelandt; Jean-Marc Taymans
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

2.  The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization.

Authors:  B Titz; T Low; E Komisopoulou; S S Chen; L Rubbi; T G Graeber
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

3.  Ancient origin of the Parkinson disease gene LRRK2.

Authors:  Ignacio Marín
Journal:  J Mol Evol       Date:  2008-06-04       Impact factor: 2.395

Review 4.  The Roco protein family: a functional perspective.

Authors:  Ignacio Marín; Wouter N van Egmond; Peter J M van Haastert
Journal:  FASEB J       Date:  2008-06-03       Impact factor: 5.191

Review 5.  Phosphorylation of LRRK2: from kinase to substrate.

Authors:  Evy Lobbestael; Veerle Baekelandt; Jean-Marc Taymans
Journal:  Biochem Soc Trans       Date:  2012-10       Impact factor: 5.407

Review 6.  The function of ROCO proteins in health and disease.

Authors:  Patrick A Lewis
Journal:  Biol Cell       Date:  2009-03       Impact factor: 4.458

7.  Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2.

Authors:  Christian Johannes Gloeckner; Karsten Boldt; Felix von Zweydorf; Sandra Helm; Ludwig Wiesent; Hakan Sarioglu; Marius Ueffing
Journal:  J Proteome Res       Date:  2010-04-05       Impact factor: 4.466

8.  Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease.

Authors:  Xianting Li; Qing Jun Wang; Nina Pan; Sangkyu Lee; Yingming Zhao; Brian T Chait; Zhenyu Yue
Journal:  PLoS One       Date:  2011-03-01       Impact factor: 3.240

9.  LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.

Authors:  Jean-Marc Taymans; Renée Vancraenenbroeck; Petri Ollikainen; Alexandra Beilina; Evy Lobbestael; Marc De Maeyer; Veerle Baekelandt; Mark R Cookson
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

10.  Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers.

Authors:  Laura Civiero; Renée Vancraenenbroeck; Elisa Belluzzi; Alexandra Beilina; Evy Lobbestael; Lauran Reyniers; Fangye Gao; Ivan Micetic; Marc De Maeyer; Luigi Bubacco; Veerle Baekelandt; Mark R Cookson; Elisa Greggio; Jean-Marc Taymans
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more
  2 in total

1.  Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7.

Authors:  Ruth Chia; Sara Haddock; Alexandra Beilina; Iakov N Rudenko; Adamantios Mamais; Alice Kaganovich; Yan Li; Ravindran Kumaran; Michael A Nalls; Mark R Cookson
Journal:  Nat Commun       Date:  2014-12-15       Impact factor: 14.919

2.  Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways.

Authors:  Lauran Reyniers; Maria Grazia Del Giudice; Laura Civiero; Elisa Belluzzi; Evy Lobbestael; Alexandra Beilina; Giorgio Arrigoni; Rita Derua; Etienne Waelkens; Yan Li; Claudia Crosio; Ciro Iaccarino; Mark R Cookson; Veerle Baekelandt; Elisa Greggio; Jean-Marc Taymans
Journal:  J Neurochem       Date:  2014-07-14       Impact factor: 5.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.